Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Visx v. B&L

This article was originally published in The Gray Sheet

Executive Summary

Santa Clara, California eye laser manufacturer files suit in Delaware district court against Bausch & Lomb for infringement of its '388 patent on Sept. 19, the same day Visx received a reexamination certificate for the patent from the U.S. Patent and Trademark Office. The reissued patent covers 60 new claims and will expire in 2009. Since February, when B&L began marketing its Technolas 217 eye laser, the Rochester, New York company has denied the need to obtain rights under third-party patents (1"The Gray Sheet" Feb. 28, 2000, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel